---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-045459"
form_type: "8-K/A"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2023-12-19T23:59:59+00:00"
generated_at: "2026-06-07T10:49:29.101716+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Semper Paratus shareholders approve extension to Sep 2024; $9.7M redeemed

## Summary
- Shareholders approved extension of deadline to September 15, 2024 via one 3-month and six 1-month extensions.
- 880,873 Class A shares redeemed at ~$11.02/share for aggregate ~$9.7 million.
- Trust account balance after redemptions and $67,500 payment is ~$16.5 million.
- First extension to March 15, 2024 triggered by $67,500 deposit into trust.
- Amendment to charter filed with Cayman Registrar to allow the extensions.

## SEC filing metadata
- accession: 0001493152-23-045459
- form_type: 8-K/A
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2023-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-045459
- JSON: https://secwatch.observer/filing/0001493152-23-045459.json
- Plain text: https://secwatch.observer/filing/0001493152-23-045459.txt

## Key facts
- Governance Changes
  Tevogen Bio Holdings Inc.: Adopted and filed an amended charter to extend the deadline for an initial business combination to September 15, 2024, with a series of extension mechanisms and required deposits into the trust account (effective 2023-12-19).
  - Change: charter amendment
  - Effective: 2023-12-19
  source text: At the Extraordinary General Meeting, the Shareholders approved the Extension Amendment Proposal for the Company to adopt and file the Amended Charter, which the Company promptly filed following the Shareholders’ approval.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm
- Shareholder Votes
  Tevogen Bio Holdings Inc. shareholders approved Extension Amendment Proposal.
  - Outcome: passed
  source text: The Shareholders approved the Extension Amendment Proposal. The following is a tabulation of the voting results: Ordinary Shares: Votes For Votes Against Abstentions Broker Non-Votes 14,359,632 5,967 0 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315223045459/0001493152-23-045459-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.